Expert Witness Profile · Expert S123R
This expert is a Ph.D. pharmacologist and biochemist with more than two decades at a major pharmaceutical company, rising to principal scientist, specializing in cancer and antiviral drug discovery, mechanism of action, and clinical development.
Expertise spans nucleotide and enzyme-inhibitor chemotherapeutics, fluoropyrimidine pharmacology and dihydropyrimidine dehydrogenase inhibition, ribonucleotide reductase inhibitors, antiviral mechanisms including herpes simplex and HIV reverse transcriptase inhibitors, enzyme kinetics, drug metabolism and pharmacokinetics, and clinical trial design and FDA documentation.
This expert has served as an expert witness or consultant in at least six litigation matters retained by major national law firms, with two trial or hearing testimonies. Attorneys retain this expert for pharmaceutical patent matters turning on mechanism of action, obviousness disputes, and cases involving oncology and antiviral therapeutics.
Credentials
Formal Education
- Ph.D. in Pharmacology from Yale University
- B.A. in Psychology and Philosophy from the University of Vermont
Why Attorneys Retain This Expert
Expert Qualifications
- More than two decades at a major pharmaceutical company, rising to principal scientist
- Expert or consultant in at least six litigation matters since 2003
- Two trial or hearing testimonies in pharmaceutical patent matters
- Retained by major national law firms on mechanism of action issues